Regenxbio Inc. (RGNX) PT Raised to $82 at Barclays

September 14, 2021 4:36 AM EDT
Get Alerts RGNX Hot Sheet
Price: $7.40 +2.21%

Rating Summary:
    14 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Barclays analyst Gena Wang raised the price target on Regenxbio Inc. (NASDAQ: RGNX) to $82.00 (from $79.00) while maintaining a Overweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change